Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-20

Clinical Trial Update: A Study to Evaluate MWN109 Tablets in Healthy Adult Participants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating MWN109 tablets in healthy adults with overweight or obesity; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MWN109

Snippet

Sponsor: Shanghai Minwei Biotechnology Co., Ltd | Conditions: Overweight or Obesity | Phase 1 | Status: RECRUITING